Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration

International Ophthalmology

Volumn 33, Issue 5, 2013, Pages 485-491

  Ulaş, Fatih ^a,b   Balbaba, Mehmet ^c   Özmen, Sedat ^a,d   Çelebi, Serdal ^a   Doğan, Ümit ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b MALATYA STATE HOSPITAL   (Turkey)

^c Malatya EGM Hayat Hospital Ophthalmology Clinic   (Turkey)

^d Suluova State Hospital   (Turkey)

Author keywords

Age related macular degeneration; Body mass index; C reactive protein; Dehydroepiandrosterone sulfate; Serum lipids

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RETINA MACULA AGE RELATED DEGENERATION; SMOKING HABIT; VISUAL ACUITY;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; ODDS RATIO;

EID: 84890176366     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-013-9728-4     Document Type: Article

References (27)

1. Nowak JZ (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58(3):353-363 (Pubitemid 44111070)
2. Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47(8 Suppl):C19-C31
3. Seddon JM, George S, Rosner B, Rifai N (2005) Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123(6):774-782 (Pubitemid 41056598)
4. Auchus RJ (2004) Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 22(4):281-288 (Pubitemid 40030078)
5. Altman R, Motton DD, Kota RS, Rutledge JC (2008) Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vasc Pharmacol 48(2-3):76-84
6. Bastianetto S, Ramassamy C, Poirier J, Quirion R (1999) Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66(1-2):35-41 (Pubitemid 29148331)
7. Legrain S, Girard L (2003) Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging 20(13):949-967 (Pubitemid 37363658)
8. Tamer C, Oksuz H, Sogut S (2007) Serum dehydroepiandrosterone sulphate level in age-related macular degeneration. Am J Ophthalmol 143(2):212-216 (Pubitemid 46136164)
9. Saggini A, Anogeianaki A, Maccauro G, Tete S, Salini V, Caraffa A, Conti F, Fulcheri M, Galzio R, Shaik-Dasthagirisaheb YB (2011) Cholesterol, cytokines and diseases. Int J Immunopathol Pharmacol 24(3):567-581
10. Dasari B, Prasanthi JR, Marwarha G, Singh BB, Ghribi O (2011) Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol 11:22
11. Najafi M, Roustazadeh A, Alipoor B (2011) Ox-LDL Particles: Modified components, Cellular uptake, Biological roles and Clinical assessments. Cardiovasc Hematol Disord Drug Targets
12. Seddon JM, Reynolds R, Rosner B (2010) Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis 16:2412-2424
13. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134(3):411-431
14. Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274-278 (Pubitemid 30311864)
15. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N (2004) Association between C-reactive protein and age-related macular degeneration. JAMA 291(6):704-710 (Pubitemid 38543790)
16. Kim IK, Ji F, Morrison MA, Adams S, Zhang Q, Lane AM, Capone A, Dryja TP, Ott J, Miller JW, DeAngelis MM (2008) Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Mol Vis 14:1487-1495
17. Klein R, Klein BE, Knudtson MD, Wong TY, Shankar A, Tsai MY (2005) Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 140(1):35-44
18. McGwin G, Hall TA, Xie A, Owsley C (2005) The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol 89(9):1166-1170 (Pubitemid 41226465)
19. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111(12):1805-1812 (Pubitemid 38057722)
20. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT (2003) Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44(9):3771-3777 (Pubitemid 37047945)
21. Gutierrez G, Mendoza C, Zapata E, Montiel A, Reyes E, Montano LF, Lopez-Marure R (2007) Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells. Atherosclerosis 190(1):90-99 (Pubitemid 44932104)
22. Bucolo C, Drago F, Lin LR, Reddy VN (2005) Neuroactive steroids protect retinal pigment epithelium against oxidative stress. NeuroReport 16(11):1203-1207 (Pubitemid 41058469)
23. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C (2004) Sex steroids and age-related macular degeneration in older French women: the POLA study. Ann Epidemiol 14(3):202-208. doi: 10.1016/S1047-2797(03)00130-3 (Pubitemid 38249334)
24. Reynolds R, Rosner B, Seddon JM (2010) Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology 117(10):1989-1995
25. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Javier Nieto F, Huang GH, Pankow JS, Klein BE (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128(6):750-758
26. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31
27. Moeini HA, Masoudpour H, Ghanbari H (2005) A study of the relation between body mass index and the incidence of age related macular degeneration. Br J Ophthalmol 89(8):964-966 (Pubitemid 41081403)